60 mg retatrutide Retatrutide 60mg Pre-Filled Pen Weight

Without insurance, the out-of-pocket costs can be substantial, often ranging from several hundred to over a thousand dollars per month

It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved

For GLP-1 receptor agonists, microdosing means using doses significantly below the standard therapeutic range, typically one-fifth to one-tenth of what is prescribed for weight loss or diabetes management

[DOI] [PMC free article] [PubMed] [Google Scholar] 199.Dantas Machado A.C., Brown S.D., Lingaraju A., Sivaganesh V., Martino C., Chaix A., Zhao P., Pinto A.F.M., Chang M.W., Richter R.A., et al

If a video visit is required, it will typically be for the initial session

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules